Menopausal hormone therapy reduces risk of low bone mineral density by 69%, retrospective study finds

Women on menopausal hormone therapy face a decreased risk of low bone mineral density compared with those not using it, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.